Abstract
Objective: We assessed the efficacy of postoperatively administered oral Sotalol in preventing the occurrence of postoperative atrial fibrillation.Methods: Subjects were 80 consecutive patients undergoing coronary artery bypass grafting (CABG) randomized alternately into a Sotalol group (40 patients) administered 80 mg of oral Sotalol daily starting on the postoperative day 1 and continued for 14 days, and a control group (40 patients) matched for age and gender.Results: The incidence of postoperative atrial fibrillation (21 patients) was significantly lower in the Sotalol group (6/40 patients; 15%) than in controls (15/40; 37.5%) (p<0.05). Significant bradycardia or hypotention, necessitating drug withdrawal, occurred in 3 of 40 (7.5%) patients in the Sotalol group. None in the Sotalol group developed Torsardes de Pointes or sustained ventricular arrhythmias or other severe side effects. The sinus heart rate increased in both groups but less in the Sotalol group, QT, QRS, and QTc durations did not differ between groups. Postoperative hospital stay did not differ between groups.Conclusions: Oral Sotalol administration of 80 mg daily was associated with a significant decrease in postoperative atrial fibrillation in patients undergoing CABG without appreciable side effects. Sotalol should thus be considered in preventing postoperative atrial fibrillation in patients undergoing CABG in the absence of heart failure and significant left ventricular dysfunction.
Similar content being viewed by others
References
Rubin DA, Nieminski KE, Reed GE, Herman MV. Predictors, prevention, and long-term prognosis of atrial fibrillation after coronary artery bypass graft operations. J Thorac Cardiovasc Surg 1987;94:331–5.
Mathew JP, Parks R, Savino JS, Friedman, AS, Koch C, Mangano DT, et al. Atrial fibrillation following coronary artery bypass surgery. JAMA. 1996, 276: 300–6.
Aranki SF, Shaw DP, Adams DH, Rizzo RJ, Couper GS, VanderVliet M, et al. Predictors of atrial fibrillation after coronary artery surgery. Circulation. 1996, 94: 390–7.
Smith EEJ, Shore DF, Monro JL, Ross JK. Oral Verapamil fails to prevent supraventricular tachycardia following coronary artery surgery. Int J Cardiol. 1985, 9: 37–44.
Davidson R, Hartz R, Kaplan K, Parker M, Feiereisel P, Michaelis L. Prophylaxis of supraventricular tachycardia after coronary bypass surgery with oral verapamil: a randomized, double-blind trial. Ann Thorac Surg. 1985, 39: 336–9.
Suttorp MJ, Kingma JH, Gin MTJ, Hermel NM, Koomen EM, Defauw JAM, et al. Efficacy and safety of low- and high-dose sotalol versus propranolol in the prevention of supraventricular tachyarrhythmias early after coronary artery bypass operations. J Thorac Cardiovasc Surg. 1990; 100: 921–6.
Daoud EG, Strickberger SA, Man KC, Goyal R, Deeb GM, Bolling SF, et al. Preoperative amiodarone as prophylaxis against atrial fibrillation after heart surgery. N Engl J Med. 1997; 337: 1785–91.
Redle JD, Khurana S, Marzan R, McCullough PA, Stewart JR, Westveer DC, et al. Prophylactic oral amiodarone compared with placebo for prevention of atrial fibrillation after coronary artery bypass surgery. Am Heart J. 1999; 138: 144–50.
Ivey MF, Ivey TD, Bailey WW, Williams DB, Hessel HEA, Miller DW. Influence of propranolol on supraventricular tachycardia early after coronary artery revascularization. J Thorac Cardiovasc Surg. 1983; 85: 214–8.
Paull DL, Tidwell SL, Guyton SW, Harvey E, Woolf RA, Holmes JR, et al. Beta blockade to prevent atrial dysrhythmias following coronary bypass surgery. Am J Surg. 1997, 173: 419–21.
Ali IM, Sanalla AA, Clark V. Beta-blocker effects on postoperative atrial fibrillation. Eur J Cardiothorac Surg. 1997; 11: 1154–7.
Williams JB, Stephanson LW, Halford FO, Langer T, Dunkam WB, Josephson ME. Arrhythmia prophilaxis using propranolol after coronary artery surgery. Ann Thorac Surg. 1982; 32: 435–8.
Parikka H, Toivonen L, Heikkila L, Virtanen K, Jarvinen A. Comparison of sotalol and metoprolol in the prevention of atrial fibrillation after coronary artery bypass surgery. J Cardiovasc Pharmacol. 1998; 31: 67–73.
Gomes JA, IP J, Santoni-Rugiu F, Mehta D, Ergin A, Lansman S, Pe E. Oral d.l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 1999; 34: 334–9.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Matsuura, K., Takahara, Y., Sudo, Y. et al. Effect of Sotalol in the prevention of atrial fibrillation following coronary artery bypass grafting. Jpn J Thorac Caridovasc Surg 49, 614–617 (2001). https://doi.org/10.1007/BF02916225
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02916225